The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Milipraz 12.5 mg/125 mg Tablets for Dogs



Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/136/001

Main Information

Trade NameMilipraz 12.5 mg/125 mg Tablets for Dogs
Active SubstancesMilbemycin oxime
Praziquantel
Dosage FormTablet
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
License Holder AddressIda Industrial Estate
Dublin Road
Loughrea
Co. Galway
Galway
Ireland
Licence NumberVPA10987/136/001

Group Information

ATC CodeQP54AB51 milbemycin oxime, combinations
Therapeutic ClassEndectoparasiticides
SpeciesDogs

Status

License statusAuthorised
Licence Issued14/06/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back